leisure time -WSS

leisure time

author：leisure time 2025-09-29 18:17:45 - browse：75

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： The problems with dementia villages

explore

WSS

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Health tech investors get more selective as pandemic boom fades

Global childhood vaccinations edge closer to pre

Federal judge rules Oregon’s tough new gun law is constitutional

STAT Readout: Friday, Oct. 20 biotech updates

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

leisure time

leisure time

knowledge

Medicare details structure of new drug price negotiation program

STAT Summit: Meghan O’Rourke on making chronic illness visible

Psychedelics group wrestles with new pharma identity

Smaller biotechs seek to piggyback on weight loss drug boom

Dobbs anniversary: the lost opportunity of abortion as health care

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Apple is now the first public company to be valued at $3 trillion

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Guidelines to prevent youth baseball injuries need more muscle

CZI to create biohub to build anti

focus

UnitedHealth, Optum discontinue NaviHealth name

STAT Readout: Friday, Oct. 20 biotech updates

Blood tests recalled over risk of missed heart attack diagnosis

Care demand spikes challenge UnitedHealth’s provider arm

STAT Summit: Meghan O’Rourke on making chronic illness visible

Study on Amgen’s bispecific immunotherapy produces positive data

hotspot

explore

focus

hotspot